Figure 3From: Efficacy and safety of inhaled formoterol 4.5 and 9 μg twice daily in Japanese and European COPD patients: Phase III study results Percentage of patients with a SGRQ improvement rate > 4; *p < 0.001 vs. placebo.Back to article page